chr1-108903235-G-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000264126.9(GPSM2):c.1062+1G>T variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000105 in 1,517,686 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
ENST00000264126.9 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPSM2 | NM_013296.5 | c.1062+1G>T | splice_donor_variant | ENST00000264126.9 | NP_037428.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPSM2 | ENST00000264126.9 | c.1062+1G>T | splice_donor_variant | 1 | NM_013296.5 | ENSP00000264126 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000800 AC: 2AN: 249976Hom.: 0 AF XY: 0.00000740 AC XY: 1AN XY: 135214
GnomAD4 exome AF: 0.00000513 AC: 7AN: 1365542Hom.: 0 Cov.: 22 AF XY: 0.00000584 AC XY: 4AN XY: 684472
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152144Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74320
ClinVar
Submissions by phenotype
Chudley-McCullough syndrome Pathogenic:3
Pathogenic, no assertion criteria provided | literature only | OMIM | Jun 08, 2012 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Division Of Personalized Genomic Medicine, Columbia University Irving Medical Center | Dec 13, 2021 | The c.1062+1G>T variant in the GPSM2 gene is a heterozygous canonical splice site variant, which affects an acceptor splice site in intron 9 (14 introns total; NM_013296.5). This mutation results in loss of exon 9 in the transcript and is predicted to generate a truncated protein, p.Arg318Argfs*8 (PMID: 22578326). Homozygous or compound heterozygous loss-of-function variants in GPSM2 have been reported in patient cohorts with Chudley-McCullough syndrome (PMID: 22578326). This variant in a homozygous state has been reported in two families with autosomal recessive Chudley-McCullough syndrome (PMID: 22578326 and 27312216). This variant has not been observed in the Genome Aggregation Database (gnomAD), indicating it is not a common benign variant in the populations represented in this database. This variant has been reported in the ClinVar database as a pathogenic variant (Variant ID: 35494; last accessed 12/13/2021). - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Sep 17, 2024 | Variant summary: GPSM2 c.1062+1G>T is located in a canonical splice-site and is predicted to affect mRNA splicing resulting in a significantly altered protein due to either exon skipping, shortening, or inclusion of intronic material. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing and loss of GPSM2 function. Several computational tools predict a significant impact on normal splicing: Four predict the variant abolishes a 5' splicing donor site. At least one publication reports experimental evidence that this variant affects mRNA splicing, resulting in the skipping of exon 9 (Doherty_2012). The variant allele was found at a frequency of 8e-06 in 249976 control chromosomes. c.1062+1G>T has been reported in the literature in individuals affected with Chudley-McCullough Syndrome (e.g. Doherty_2012, Carlson_2023). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 22578326, 36633841). ClinVar contains an entry for this variant (Variation ID: 35494). Based on the evidence outlined above, the variant was classified as pathogenic. - |
not specified Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 02, 2016 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Nov 10, 2023 | Canonical splice site variant predicted to result in a null allele in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 22578326, 27312216, 36147510) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at